chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he received his first dose of the vaccine on 22Dec2020 and tested positive for Covid yesterday (04Jan2021).; he received his first dose of the vaccine on 22Dec2020 and tested positive for Covid yesterday (04Jan2021).; This is a spontaneous report from a contactable other healthcare professional (patient). A male patient of an unspecified age started to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), unspecified route of administration on 22Dec2020 as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  He received his first dose of the vaccine on 22Dec2020 and tested positive for COVID yesterday (04Jan2021). He stated his "symptoms were general at first, then weakness after 10 days, chilly and muscle strain".  The other HCP reported "do I need to take the second dose on 11Jan2021?" The patient underwent lab tests and procedures which included COVID test: result positive on 04Jan2021.   Outcome of the event he received his first dose of the vaccine on 22Dec2020 and tested positive for COVID yesterday (04Jan2021) was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The reported positive test for Covid after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.
Information has been received from a consumer concerning an approx. 1 year old male, with no known drug allergies and a history of three tympanic membrance surgeries, tonsillectomy and adenoidectomy, who in approx. 9/98, was vaccinated with MMR II. The pt's mother reported that the night of the vaccination, she woke up to the child making a strange humming sound. She reported that she went to the crib and the child looked swollen and was hot to the touch. The pt's mother took a rectal temperature and the result was 105.8F. She bathed him in tepid water and gave the child Tylenol. The pt's mother took him to the physician, who did not feel the events were vaccine related. Later that evening, it was reported that the child developed a 'measles-like rash' that went away within a couple of hours. The child had computed axial tomography scan in November 2000  that showed "hypoplasmia (organ not specified) and other significant abnormalities" on the right side only (pre-existing conditions)(follow-up in process). The report mentioned possible old injury or insult. The patient can not hear with the right ear and is losing his eyesight It was reported that the patient is always sick upon internal review the patient's experience were determined to be Other Medical Events. FOLLOW-UP information, the physician reported that the patient was vaccinated with measles virus vaccine live (-) mumps virus vaccine live (-) rubella virus vaccine live (second generation) on 10/02.1998. Concomitant vaccination on 10/02/1998 included varicella virus vaccine live. Patient also received tuberculin purified protein deriative (PPD) on 10/02/1998. The physician reported that the patient was seen in the clinic on 10/07/1998 with low grade fever (T. 99.6/Tympanic) and was diagnosed with bilateral otitis media (BOM), tonsillitis and rash (? post vaccination vs. viral). A complete blood count (CBC) was done and was consistent with a viral infection.  Chest x-ray was negative. The physician stated "I don't feel there was any adverse reaction". Additional information has been requested. In follow-up, the physician reported tha the pt was vaccinated with MMR on 10/02/1998. Concominant vaccination on 10/02/1998 icluded varicella virus vaccine. Pt also received tuberculin purified protein derivative on 10/02/1998. The physician reported that the pt was seen in the clinic on 10/07/1998 with low grade fever (99.6 deg. F) and was diagnosed with bilateral otitis media, tonsillitus and rash post vaccination. A complete blood count CBC was done and was consistent with a viral infection. Chest x-ray was negative. Antistreptolysin 0 titer, blood culture and Epstein Barr virus titers were negative. The physician stated, "I don't feel there was any adverse reaction." Additional info has been requested.
30 hours after the first Covid vaccination, the resident was lethargic, non responsive with shortness of breathe.
By 6pm that night I developed a severe migraine. The next morning I woke up and had no vision in my left eye. I went to Urgent Care and they me a shot of Toradol and Benadryl and sent me home. The headache remained for 4 days and my vision was slowly getting better. For almost a year now I'll get those severe migraines and vision loss. Two months ago (02/01/2022) I went for my yearly eye exam, and my Dr. gave me a Field of Vision test that showed that I've lost 90% of my vision in my left eye. I am presently being sent for a Doppler exam of my Carotid Artery, then I'll be getting a referral for a Neurologist.
she has been having horrific side affects; Initial information regarding an unsolicited valid non serious case was received from other health professional via Agency (Reference number- 00884479) and transmitted to Sanofi on 03-Dec-2021.  This case involves a 56-year-old female patient who had been having horrific side effects (adverse event) after receiving INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  In march 2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE [lot UJ273AB, expiry date not reported] via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious she has been having horrific side effects (adverse event) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  It was reported "Nurse reports that a 56 year-old patient; AG has called multiple times, leaving messages complaining of "horrific side effects" from receiving the FLUZONE vaccine in march of 2021. Patient has not specified what those side effects."  No laboratory data was reported.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the reported event.
After vaccine administration the patient started bleeding profusely and swelling occurred at injection site. The patient's arm was elevated and pressure was applied which stopped the bleeding. A cold compress was applied to swelling at injection site for 15 mins and patient was observed by pharmacy staff. After 15 minutes, the swelling had gone down, there was no further bleeding and the patient was sent home.
This spontaneous report was received from a registered nurse, regarding a patient of unknown age and gender. The patient's concomitant medications included sterile diluent (lot # and expiration date were not provided). The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On an unspecified date, the patient was vaccinated with an improperly stored dose of (wistar ra 27-3) M-M-R II, lot #N031294 with expiration date 21-AUG-2019, for prophylaxis (dose number, frequency, route and anatomical location were not provided).The administered dose of the vaccine experienced a temperature excursion in the range between 47°F to 77°F (52.7°F) during 2 hours and 15 minutes. The vaccines had not had any previous temperature excursions.There were no adverse effects reported. This is one of eleven reports received from the same reporter. Sender's Comments: US-009507513-1808USA006003: US-009507513-1808USA011005: US-009507513-1808USA011006: US-009507513-1808USA011008: US-009507513-1808USA011009: US-009507513-1808USA011010: US-009507513-1808USA011011: US-009507513-1808USA011012: US-009507513-1808USA011013: US-009507513-1808USA011014.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown dates, an unspecified number of patients were vaccinated with improperly stored doses of GARDASIL (lot numbers, expiration dates, doses and routes of administration were not provided). No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Redness swelling around R eye 24hrs after injection coughing and chest congestion.      12/7/09 Medical records received for DOS 11/18/09. FINAL DX: URI recent H1N1, allergic reaction.  R eye edema 24 hrs s/p H1N1.  C/O sinus congestion, nonproductive cough. Cervical adenopathy. Allergic rxn and URI. Abx therapy and Benadryl as tx.
normal 4 moth old infant received DTP/OPV in office at on 28Mar90, put to bed at 10:00pm; found dead at 10:30 pm.
1st dose 28Dec2019, 2nd not yet; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (first dose received many years ago from reporting of Shingles vaccine (Zostavax)) and Shingrix (first dose received on arm via intramuscularly route 3 years 2 months ago on 28th December 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 21-Feb-2023 Reporter's comment: This case was self-reported by the patient.  The patient received the vaccine at a pharmacy facility.  The patient does not recall in which arm the vaccine was injected.  The patient had not yet received the second dose of Shingrix. The reporter did not consent to follow up.  The reporter did not provide consent to follow up with healthcare professional but welcomed follow up with him. All the information was not available.  Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination. VAERS details were reported for 1st dose.
Patient presented to the ED 10/10/21 with fevers, fatigue/malaise and constipation since 10/8.  He underwent week #4 chemotherapy with carboplatin and Taxol on 10/7. He was admitted for IV antibiotics and continued close monitoring while awaiting culture results. Since admission, he has demonstrated overall clinical improvement, though did have ongoing low grade fevers overnight. He was able to continue radiation therapy during his hospital stay. ED Visit and hospital admission within 6 weeks of receiving the COVID vaccine.
I've had reactions to all three dosages, which includes a rash around my ears and neck, but this time, I've developed clusters of (what appears to be) skin tags near the rash site. All three episodes is/was more active on my left side, which is the side I received all three vaccines, due to being diagnosed with breast cancer 3/2021.
transient pain behind L eye followed by slurred speech x 15-20 minutes about 2 hours after administration of vaccine
5 patients received a Moderna booster shot of 0.5ml (not 0.25ml); This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL OVERDOSE (5 patients received a Moderna booster shot of 0.5ml (not 0.25ml)) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milligram. On 29-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (5 patients received a Moderna booster shot of 0.5ml (not 0.25ml)). On 29-Oct-2021, ACCIDENTAL OVERDOSE (5 patients received a Moderna booster shot of 0.5ml (not 0.25ml)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Approx 1 wk after receiving TD booster, pt reports that arm is still sore. Deltoid/ injection site is inflammed. Recommended ibuprofen and report back if no improvement.
COVID+ 10/31/22 - Vaccination Status - Moderna x3, pfizer x1 BRIEF OVERVIEW: Admission Date: 10/31/2022 Discharge Date: 11/3/2022 ?  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19   HOSPITAL COURSE: Patient is a 82 y.o. female  who presents to hospital with weakness.  Patient has a senior companion who visit her a week ago.  Unknown to her, she was sick with COVID.  Approximately 5 days ago the patient began having sore throat cough and fatigue.  Appetite was very poor.  She subsequently developed some diarrhea and increasing weakness.  Today she was very weak and began feeling short of breath in addition to cough.  Denies any fevers chills loss of smell or taste but has had a poor appetite and poor oral intake.  She presented to the emergency department where she was afebrile with stable vital signs.  She was not hypoxic.  Chest x-ray did not reveal any acute abnormalities.  She was COVID positive.  Lab findings revealed stable renal function and mild hyponatremia.  She had a normal white blood cell count.  Because of her progressive weakness she was referred to the hospital for further evaluation and care.  Patient was admitted and monitored.  Her inflammatory markers began to resolve.  Her respiratory status stabilized and she was seen on the day of DC ready to go.  PT/OT recommend HHN/PT/OT.  Care management making arrangements for services.  She was subsequently discharged home with Services to resume medications as previously ordered.  She can return to activity as tolerated under supervision of PT/OT. She can resume her sodium and fluid restricted diet.  She was admonished to maintain isolation for at least the next 2 days then may relax isolation but would recommend wearing mask in public for the next 7-10 days.  She was recommended to follow up with her PCP in 7-10 days as well.  She understood all these instructions and was discharged home in stable condition.
Very weak for 2-3 weeks after - still weak now.; Also having intense sun sensitivity, especially on scalp.; Feels like needles; lightheadedness./dizziness; nausea; increased heart rate; palpitations; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 30Mar2021 13:00 (Lot number: E8730) at the age of 56 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "known allergies: sulfa" (unspecified if ongoing); "known allergis: penicillin" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Known allergies: cipro, reaction(s): "allergy"; Known allergies: bactrim, reaction(s): "Allergy". The following information was reported: ASTHENIA (non-serious) with onset 30Mar2021, outcome "not recovered", described as "Very weak for 2-3 weeks after - still weak now."; PHOTOSENSITIVITY REACTION (non-serious) with onset 30Mar2021, outcome "not recovered", described as "Also having intense sun sensitivity, especially on scalp."; PARAESTHESIA (non-serious) with onset 30Mar2021, outcome "not recovered", described as "Feels like needles"; DIZZINESS (non-serious) with onset 30Mar2021, outcome "not recovered", described as "lightheadedness./dizziness"; NAUSEA (non-serious) with onset 30Mar2021, outcome "not recovered", described as "nausea"; HEART RATE INCREASED (non-serious) with onset 30Mar2021, outcome "not recovered", described as "increased heart rate"; PALPITATIONS (non-serious) with onset 30Mar2021, outcome "not recovered", described as "palpitations". The events "very weak for 2-3 weeks after - still weak now.", "also having intense sun sensitivity, especially on scalp.", "feels like needles", "lightheadedness./dizziness", "nausea", "increased heart rate" and "palpitations" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of asthenia, photosensitivity reaction, paraesthesia, dizziness, nausea, heart rate increased, palpitations.  Additional Information: Very weak for 2-3 weeks after still weak now. Also having intense sun sensitivity, especially on scalp. Feels like needles upon brief sun exposure and dizziness, lightheadedness, nausea. Also, increased heart rate palpitations. The Patient did not receive any vaccine with in 4 weeks and received medication within last 2 weeks.  Follow-up attempts are completed. No further information is expected.
Received vaccine 11/13/12. Had tender right arm on 11/14/12. Felt weak in arm. Had temp of 102, nausea, headaches, body aches at same time. Still tender in arm, but improved by 11/19/12.
FIRST COVID VACCINE WAS SUCCESSFULLY ADMINISTERED & WHILE PATIENT STILL SEATED IN CHAIR, BEGAN TO FALL TO ONE SIDE.  THE IMMUNIZER GRABBED HIS ARM SO THAT HE WOULDN'T FALL OVER AND NOTICED HE WAS SHAKING.  HE QUICKLY GAINED CONCIOUSNESS AND WAS BREATHING NORMALLY AND AWARE.  HE WAS VERY PALE AND SWEATING & WHEN WE CHECKED HIS BP IT WAS LOW.  WE ALSO APPLIED ICE PACK TO HIS FOREHEAD, BACK OF NECK AND WRISTS & CALLED EMS.  THEY ARRIVED AND CHECKED PATIENT AND EVERYTHING WAS NORMAL.
Area of bright redness of skin measuring from area of injection (left deltoid) down 28 cm to the antecubital region, approx 10 cm wide. Minimally painful. Slightly swollen.
101.3 fever, less than 24 hours persisted. Mom states high fever and fussy at 6 hours after leaving clinic and by the next day resolved.
the area is a little itchy; injection site reaction; swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm.; feeling fatigued; Initial information was received on 14-Jun-2023 regarding an unsolicited valid non-serious case received from an other health professional (Nurse).  This case involves a 51 years old female patient who experienced the area is a little itchy, injection site reaction, swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm and feeling fatigued after being vaccinated with yellow fever vaccine [YF-VAX].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included typhoid vaccine live oral (typhoid vaccine live oral) for Prophylactic vaccination (Immunisation).  On 08-Jun-2023, the patient received suspect yellow fever vaccine (strength: standard) at dose of 0.50 ml once (lot: UJ819AA, expiration date: 18-Apr-2023) via subcutaneous route in the left arm for immunization (immunisation).  On 11-Jun-2023 the patient developed a non-serious events of the "area is a little itchy" (vaccination site pruritus), "injection site reaction" (vaccination site reaction), "swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm" (vaccination site swelling) and "feeling fatigued" (fatigue) 3 days following the administration of yellow fever vaccine.  No lab data reported.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for all the events (feeling fatigued, injection site reaction, the area is a little itchy, swollen area that continues to get bigger and currently measuring 3-inches by 2-inches to the back of the left arm.).  Outcome was Not Recovered for all the events.
This case was reported by a nurse via sales rep and described the occurrence of blister in a patient who received FLUARIX QUADRIVALENT. On an unknown date, the patient received FLUARIX QUADRIVALENT .5 ml. On an unknown date, an unknown time after receiving FLUARIX QUADRIVALENT, the patient experienced blister and swelling. On an unknown date, the outcome of the blister and swelling were unknown. It was unknown if the reporter considered the blister and swelling to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The other healthcare professional called to report that she did not like the FLUARIX QUADRIVALENT vaccine because 3 patients received the vaccine in 2014 and experienced blisters and swelling. The sales representative did not have any further information. This case has been linked to cases US2016031743 and US2016GSK034532, reported by the same reporter.
The morning after I got injection #2, I woke up and had to run to the bathroom to throw up violently. I broke blood vessels in my face. Since then, I've thrown up 2 other mornings, including today, and have been so nauseous part of each day.
Constant headache starting at the base of the skull with regular escalation that is accompanied by lightheadedness, arm weakness, fatigue, eye pain, ptosis, and facial numbness. Headache has persisted since onset (4/13/2021) to the time of this reporting (11/1/2021). A MRI brain scan was normal, and traditional headache treatments have been ineffective. A CT myelogram also came back normal.
Approximately 5 minutes after vaccine administered,  pt c/o rash on arms: upper arms and forearms, splotchy, scattered red macular lesions appox 0.5-1 inch in diameter. No rash to face, trunk, abdomen or legs. No urticarial lesions. No itching. No swelling to eyes, face or lips. No respiratory compromise.   45mg oral Benadryl given in clinic. After 15 minutes, lesions began
Given second COVID vaccine 2/2/2021, tested COVID positive on 2/58/2021 due to outbreak and with cough and fatigue.
Freezing cold; Arm hurt; Covid arm/covid arm all the way down her hand; Couldn't eat; Couldn't sleep; Left side of her neck was extremely sweaty; Eyes hurt; Can't breathe well; Throat hurt; Nose hurt; Felt like she was going to die; Chills; Fatigued; Massive headache/Headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Freezing cold), PAIN IN EXTREMITY (Arm hurt), VACCINATION SITE REACTION (Covid arm/covid arm all the way down her hand), FEEDING DISORDER (Couldn't eat) and INSOMNIA (Couldn't sleep) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING COLD (Freezing cold), PAIN IN EXTREMITY (Arm hurt), VACCINATION SITE REACTION (Covid arm/covid arm all the way down her hand), FEEDING DISORDER (Couldn't eat), INSOMNIA (Couldn't sleep), HYPERHIDROSIS (Left side of her neck was extremely sweaty), EYE PAIN (Eyes hurt), DYSPNOEA (Can't breathe well), OROPHARYNGEAL PAIN (Throat hurt), NASAL DISCOMFORT (Nose hurt), FEELING ABNORMAL (Felt like she was going to die), CHILLS (Chills), FATIGUE (Fatigued) and HEADACHE (Massive headache/Headache). At the time of the report, FEELING COLD (Freezing cold), PAIN IN EXTREMITY (Arm hurt), VACCINATION SITE REACTION (Covid arm/covid arm all the way down her hand), FEEDING DISORDER (Couldn't eat), INSOMNIA (Couldn't sleep), HYPERHIDROSIS (Left side of her neck was extremely sweaty), EYE PAIN (Eyes hurt), DYSPNOEA (Can't breathe well), OROPHARYNGEAL PAIN (Throat hurt), NASAL DISCOMFORT (Nose hurt), FEELING ABNORMAL (Felt like she was going to die), CHILLS (Chills), FATIGUE (Fatigued) and HEADACHE (Massive headache/Headache) outcome was unknown.            No concomitant or treatment drug reported by reporter.   This case was linked to MOD-2021-283872 (Patient Link).